Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1320 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-15

Study Completion Date

2020-11-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the performance of a non-invasive olfactory device as a rapid indicator of COVID-19 in positive subjects.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

NCT05855369

Smell Dysfunction Olfactory Disorder Long COVID

RECRUITING PHASE2/PHASE3

Anosmia and Covid-19

NCT05246059

Anosmia SARS CoV 2 Infection

COMPLETED NA

Can the Electronic Nose Smell COVID-19?

NCT04475562

SARS-CoV Infection Covid19

COMPLETED NA

Rapid Screening for Olfactory Disorders in Covid-19 Infection

NCT04696601

Olfaction Disorders COVID-19 Testing

WITHDRAWN NA

COVID-19 Anosmia Study

NCT04495816

Anosmia Covid19

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The major hypothesis is that a quantitative and unbiased smell test will be a useful tool to identify COVID-19 positive individuals.

The study will address what fraction of outpatients truly have a loss-of-smell (including a partial loss) and is expected to outperform the current question that is used to identify COVID-19 related anosmia "Do you have a new loss of smell or taste?" (yes/no) in terms of sensitivity and specificity.

The study will address if high-risk asymptomatic people whom are SARS-CoV-2 positive have a partial (or perhaps transitory) loss of smell.

The primary objective of this study is to validate the utility (sensitivity, specificity and accuracy) of a quantitative non-biased olfactory device for the rapid identification of SARS-CoV-2 infected subjects (as identified by PCR). The performance of the device will also be compared to the standard CDC patient query for 'new loss of smell or taste'.

The secondary objective is to test if SARS-CoV-2 positive 'asymptomatic' COVID-19 subjects may actually present with a mild or transitory defect in smell (hyposmia), which is revealed through our quantitative olfactory smell test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Outpatients (Drive Thru)

Patients receiving testing through a drive thru location.

olfactory device

Intervention Type DEVICE

A quantitative non-biased olfactory device intended for the rapid identification of SARS-CoV-2 infected subjects (as identified by PCR).

High Risk Asymptomatics

Asymptomatic patients (residents) in a high risk location.

olfactory device

Intervention Type DEVICE

A quantitative non-biased olfactory device intended for the rapid identification of SARS-CoV-2 infected subjects (as identified by PCR).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

olfactory device

A quantitative non-biased olfactory device intended for the rapid identification of SARS-CoV-2 infected subjects (as identified by PCR).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Have a corresponding PCR test for SARS-CoV-2 on the same day.

Exclusion Criteria

* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers)
* Pregnant women
* Individuals with allergic to fragrances
* History of surgery on the nose or paranasal sinuses
* Asthmatics
* Patients with known neurocognitive disorders: dementia, Alzheimer's disease, Parkinson's disease
* Adults with Acute or Chronic rhinosinusitis (They will be asked if they have a 'stuffy or runny nose'; they may be included in some tests, but their analysis would be segregated as they may be false positives due to allergies or a common cold or flu)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No